Chronic Kidney Disease Market – Overview
Also known as chronic kidney failure, the chronic kidney disease is a gradual loss of kidney function. The kidney filters waste and excess fluids from the blood. These waste products are then excreted through the urine. In the advanced stage of the disease, the levels of fluid, electrolytes, and waste products are elevated in the body. The treatment of the disease depends on the stage of the disease. At the early stage, treatment methods focus on preventing kidney damage, while at the end-stage it is treated through dialysis and kidney transplant. Various indications for the chronic kidney disease are Type 1 or Type 2 diabetes, high blood pressure, glomerulonephritis, interstitial nephritis, polycystic kidney disease, and others.
Key drivers for the growth of the market are increasing the prevalence of kidney diseases, increasing number of biopsy procedures, and the rising demand for new techniques for diagnosis of chronic diseases. Moreover, the availability of various diagnostic tests for kidney diseases also influences the growth of the market. The increasing number of market players is also expected to stimulate the growth of the market during the forecast period. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) stated that the kidney disease is frequently referred to as a “silent disease” as there are no symptoms in its early stages and can go undetected. The disease is a global health burden risk factor for Cardiovascular Diseases (CVDs). It also stated that the overall prevalence of chronic kidney disease in the general population is nearly 14%.
The Global Chronic Kidney Disease Market Is Expected To Grow At A CAGR Of 5.2% During The Forecast Period Of 2017–2023.
Avail Premium Sample copy at https://www.marketresearchfuture.com/sample_request/5744
Chronic Kidney Disease Market – Top Players
Abbott, Siemens, Sysmex, Beckman Coulter, F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., URIT Medical, Nova Biomedical, ARKRAY, OPTI Medical, 77 Elektronika, Randox Laboratories, Teva Pharmaceutical Industries Ltd., Amgen Inc., AstraZeneca Plc, Pfizer Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., GlaxoSmithKline Plc, AbbVie Inc., and Kissei Pharmaceutical Co. Ltd.
Global Chronic Kidney Disease Market – Regional Analysis;
The American chronic kidney disease market is driven by the increasing population with kidney diseases, extensive use of diagnostic tests for detecting kidney failure, and the increasing demand for new treatment options for kidney diseases.
In Europe, the market is driven by the growth of the medical device industry and the increasing awareness about risk factors for kidney diseases. Additionally, the increasing diabetic population and huge investments in the medical device sector by major market players also fuel the growth of the market. Germany, the largest market for chronic kidney diseases, is driven by the increasing emphasis on the development of new drugs, rising government support for research and development, and availability of funds for research.
Asia Pacific is the fastest growing chronic kidney disease market owing to the increasing prevalent diseases such as diabetes and cardiovascular diseases. Improving hospital infrastructure, the presence of skilled healthcare professionals, and rapid development in the healthcare technology are also expected to accelerate the growth of the market during the forecast period.
The Middle East and Africa hold the least share of the chronic kidney disease market due to limitations to technology and unawareness about kidney diseases and their treatments.
Avail Stunning Discount at https://www.marketresearchfuture.com/check-discount/5744
Intended Audience
- Pharmaceutical and Biotechnological Companies
- Research and Development (R&D) Companies
- Ambulatory Care Centers
- Academic Institutes and Universities
- Market Research and Consulting Service Providers
- Potential Investors
Global Chronic Kidney Disease Market – Segmentation:
The global chronic kidney disease market is segmented on the basis of diagnosis, treatment, indication, and end-user.
On the basis of diagnosis, it is segmented into blood test, urine test, imaging test, and kidney biopsy.
On the basis of treatment, it is segmented into drugs, dialysis, and kidney transplant. Drugs are further segmented into ace inhibitors, angiotensin-ii receptor blockers, calcium channel blockers, beta-blockers, and erythropoiesis-stimulating agents.
On the basis of indication, it is segmented into Type 1 or Type 2 diabetes, high blood pressure, polycystic kidney disease, and others.
On the basis of end-user, it is segmented into hospitals and clinics, diagnostic centers, and others.
Have Any Query, Ask to Expert at https://www.marketresearchfuture.com/enquiry/5744
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com